Engineering a pharmacologically superior form of granulocyte-colony-stimulating factor by fusion with gelatin-like-protein polymer
Engineering a pharmacologically superior form of granulocyte-colony-stimulating factor by fusion with gelatin-like-protein polymer
复制标题
通过与明胶样蛋白质聚合物融合,设计出药理优越的粒细胞集落刺激因子
DOI:
10.1016/j.ejpb.2009.12.002
复制
发表时间:
2010-03-01
影响因子:
4.9
通讯作者:
Zhou, Lin-Fu
中科院分区:
文献类型:
--
作者:
Huang, Yan-Shan;Wen, Xiao-Fang;Zhou, Lin-Fu
The plasma half-life of therapeutic proteins is a critical factor in many clinical applications Therefore, new strategies to prolong plasma half-life of long-acting peptides and protein drugs are in high demand Here, we designed an artificial gelatin-like protein (GLK) and fused this hydrophilic GLK polymer to granulocyte-colony-stimulating factor (G-CSF) to generate a chimeric GLK/G-CSF fusion protein The genetically engineered recombinant GLK/G-CSF (rGLK/G-CSF) fusion protein was purified from Pichia pastoris In vitro studies demonstrated that rGLK/G-CSF possessed an enlarged hydrodynamic radius, improved thermal stability and retained full bioactivity compared to unfused G-CSF Following a single subcutaneous administration to rats, the rGLK/G-CSF fusion protein displayed a slower plasma clearance late and stimulated greater and longer lasting increases in circulating white blood cells than G-CSF Our findings indicate that fusion with this artificial, hydrophilic, GLK polymer provides many advantages in the construction of a potent hematopoietic factor with extended plasma half-life This approach could be easily applied to other therapeutic proteins and have important clinical applications (c) 2009 Elsevier B.V All rights reserved